$Limelight Networks (LLNW.US)$
go go

大好きです！ @moomoo Rewards

$フートゥー・ホールディングス (FUTU.US)$ 以降！

$アドバンスト・マイクロ・デバイシズ (AMD.US)$ it will go back to $150 by tomo and hit $200 by year end. i believed in Lisa Su !! She will bring AMD to higher level in the meta space!

$Limelight Networks (LLNW.US)$
🦖

$フートゥー・ホールディングス (FUTU.US)$ upload around $53 .. as the bullish timing is about to start .. hit $70 by next Thursday. then dip down on Friday .. then another bull again after the next week .. My thoughts .

$フートゥー・ホールディングス (FUTU.US)$ $アップフィンテック・ホールディング (TIGR.US)$
Ladies and gentlemen, it is your friendly neighbourhood 股神 again.
After much debate and discussion on both fundamental and technical analysis, as well as brokerage and security laws with my fellow investment friends, we have collectively came to the same conclusion - these 2 stocks have indeed reached rock bottom and can only rise from here.
Some conclusions:
1. China is easing up on its regulatory grip. Refer to recent news and Biden-Xi virtual meeting discussion.
2. The fear of regulation has already been priced into both stocks.
3. 2 Possible regulatory outcomes:
A) Both companies be slapped with a fine, comply with regulations and funding limits for mainland customers onto the platforms will be imposed. (Most likely)
B) The worse that can happen is a complete ban - no new mainland customers can be acquired, but existing customers with funds already overseas is out of grip. Also, savvy investors will still be able to transfer their money overseas via various means.
To conclude, we expect both stocks to rise soon, with TIGR going up much more. We welcome you to join us on board of this train.
有危机，才有商机。
Have fun investing. Cheers!!

$スキルズ (SKLZ.US)$ 富贵险中求，CEO换了是否暴涨一次

Shares of $ファイザー (PFE.US)$ closed today at $50.87, an all-time high.
The drugmaker's previous all-time high, $50.42, was reached on Aug. 17, 2021.
Pfizer benefitted today from a number of catalysts. Barclays analysts provided a bullish forecast on potential sales of its COVID-19 antiviral Paxlovid next year.
In addition, the Biden administration said it would invest billions to boost production of COVID-19 vaccines -- singling out mRNA shots -- to increase access in poorer nations.
Pfizer could see additional upside in the coming days as the FDA may authorize boosters of its COVID-19 shot for all adults as soon as tomorrow, and a CDC advisory panel will weigh those shots in this population on Friday.

$フートゥー・ホールディングス (FUTU.US)$ 开市冲上去，已超卖